Explainer · June 10, 2026 · 5 min · By Marisol Etcheverry
Hydroquinone vs. Kojic Acid for Age Spots: Which Brightening Agent Actually Works?
Two of the most common topical ingredients promise to fade hyperpigmentation, but they work through entirely different biological mechanisms. Here is what the evidence actually shows.

If you have spent any time researching age spot treatments, you have almost certainly encountered two names repeatedly: hydroquinone and kojic acid. Both appear in prescription creams, over-the-counter serums, and dermatologist-recommended protocols. Both claim to fade dark spots. But they are not interchangeable, and understanding the difference can save you months of ineffective treatment.
What Causes Age Spots in the First Place
Age spots, clinically called solar lentigines, form when melanocytes, the pigment-producing cells in your skin, become hyperactive after years of ultraviolet exposure. The UV damage causes these cells to overproduce melanin, the pigment that gives skin its color. The excess melanin clusters in the upper layers of the epidermis and appears as flat, darkened patches. Any topical treatment worth using must interrupt this melanin production pathway at a specific biochemical step.
How Hydroquinone Works
Hydroquinone has been the clinical gold standard for decades. Its mechanism is direct and well-documented. The molecule inhibits tyrosinase, the key enzyme that converts tyrosine into DOPA and eventually into melanin. It also interferes with the synthesis of DNA and RNA within melanocytes, which slows their ability to produce pigment at the cellular level. Some research suggests it may even cause selective melanocyte cytotoxicity at higher concentrations, meaning it can partially suppress the activity of pigment-producing cells altogether.
In the United States, concentrations up to 2 percent are available over the counter. Concentrations of 4 percent and above require a prescription. Clinical studies consistently show visible fading within 4 to 8 weeks of twice-daily application when combined with broad-spectrum sunscreen. Without sunscreen, UV exposure will restimulate melanin production and undo the progress.
The drawbacks are real. Long-term use, particularly at higher concentrations, carries a risk of ochronosis, a paradoxical darkening and thickening of the skin. This complication is rare in people with lighter skin tones but more common in darker complexions using high concentrations over many months. Dermatologists typically recommend using hydroquinone in cycles: 3 months on, a break, then reassessment.
How Kojic Acid Works
Kojic acid is a byproduct of fermented rice used in sake production. Its mechanism is also tyrosinase inhibition, but it works differently from hydroquinone. Kojic acid chelates the copper ions that are essential to tyrosinase function. Without copper, the enzyme cannot catalyze the oxidation reactions that produce melanin. No copper, no functional enzyme, less pigment.
Kojic acid is generally considered gentler than hydroquinone, which makes it popular in formulations marketed toward sensitive skin. Over-the-counter concentrations typically range from 1 to 4 percent. Studies show it produces measurable lightening in solar lentigines, though the effect tends to be more gradual than hydroquinone. One 2020 review in the Journal of Dermatological Treatment found kojic acid comparable in efficacy to glycolic acid combinations, but generally slower acting than prescription hydroquinone.
The main side effect is contact dermatitis. Kojic acid can cause redness, itching, and irritation in some users, particularly at concentrations above 2 percent. It is also less stable than hydroquinone, meaning formulations can oxidize and lose potency if not properly packaged.
The Combination Approach
Many clinicians now use both agents together, sometimes adding a retinoid or azelaic acid to address melanin synthesis at multiple steps simultaneously. A combination product containing hydroquinone plus kojic acid plus a mild corticosteroid can suppress inflammation-driven pigmentation while inhibiting melanin production through two separate enzymatic pathways. This multi-pathway approach tends to produce faster and more durable results than either ingredient alone.
For patients wanting to understand how professional-grade combination protocols are applied in a clinical setting, experienced Beverly Hills dermatology teams publish detailed breakdowns of their topical and procedural approaches to pigmentation.
Which Should You Choose?
The honest answer depends on your skin tone, your sensitivity, and your timeline. Hydroquinone is the faster and more potent option, but it requires careful cycling, consistent sunscreen use, and medical supervision at higher concentrations, especially for people with medium to deep skin tones. Kojic acid is a reasonable long-term maintenance ingredient or a gentler starting point if your spots are mild or your skin is reactive.
Neither ingredient should be used without daily broad-spectrum SPF 30 or higher. Sun protection is not an optional add-on. It is the mechanism that prevents new spots from forming while the topical agent fades existing ones. Without it, you are essentially running water into a leaking bucket.
The Bottom Line
Both hydroquinone and kojic acid are legitimate, evidence-backed tools for fading solar lentigines. They share a common target, tyrosinase, but reach it through different molecular routes. Hydroquinone hits harder and faster. Kojic acid works more gently and is easier to sustain long-term. For most people with visible age spots, a supervised combination protocol, paired with non-negotiable sun protection, outperforms either ingredient used alone.
Related reading: IPL vs. Q-switched lasers for age spots.